RecruitingNCT04185935

Molecular Genetics Studies of Cancer Patients and Their Relatives

Sponsor

City of Hope Medical Center

Enrollment

999,999 participants

Start Date

Apr 18, 1997

Study Type

OBSERVATIONAL

Conditions

Malignant Neoplasm

Summary

This trial studies the genetic and behavioral factors that may contribute to the development of specific cancers and how these factors may affect the outcome of the disease in patients with a history of cancer and their relatives.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Biospecimen Collection and Questionnaire Administration for people with malignant neoplasm. The study is currently recruiting participants at 42 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiospecimen Collection

Provide a sample of blood, a saliva sample, a sample of eyebrow plucks, a sample of urine, and/or stored tumor or healthy tissue

OTHERQuestionnaire Administration

Ancillary studies

Locations(42)

Valleywise Comprehensive Health Center - Phoenix

Phoenix, Arizona, United States

John Muir Medical Center-Concord Campus

Concord, California, United States

City of Hope Medical Center

Duarte, California, United States

Saint Jude Medical Center

Fullerton, California, United States

Saddleback Memorial Medical Center

Laguna Hills, California, United States

USC / Norris Comprehensive Cancer Center

Los Angeles, California, United States

Saint Joseph Hospital - Orange

Orange, California, United States

Sutter Cancer Centers Radiation Oncology Services-Roseville

Roseville, California, United States

Cancer Center of Santa Barbara

Santa Barbara, California, United States

Lynn Regional Cancer Center - West

Boca Raton, Florida, United States

Holy Cross Hospital

Fort Lauderdale, Florida, United States

Kootenai Cancer Center

Post Falls, Idaho, United States

John H Stroger Jr Hospital of Cook County

Chicago, Illinois, United States

Rush University Medical Center

Chicago, Illinois, United States

Mercy Hospital

Cedar Rapids, Iowa, United States

Suburban Hospital

Bethesda, Maryland, United States

Frederick Oncology Hematology Associates

Frederick, Maryland, United States

Steward Saint Elizabeth's Medical Center

Brighton, Massachusetts, United States

Hunterdon Medical Center

Flemington, New Jersey, United States

Lovelace Medical Center-Downtown

Albuquerque, New Mexico, United States

New Mexico Oncology Hematology Consultants

Albuquerque, New Mexico, United States

Presbyterian Kaseman Hospital

Albuquerque, New Mexico, United States

Mount Kisco Medical Group at Northern Westchester Hospital

Mount Kisco, New York, United States

Health Quest Medical Practice PC-Cardio Thoracic

Poughkeepsie, New York, United States

Aultman Health Foundation

Canton, Ohio, United States

Saint Charles Health System

Bend, Oregon, United States

Paoli Memorial Hospital

Paoli, Pennsylvania, United States

Reading Hospital

West Reading, Pennsylvania, United States

The Don and Sybil Harrington Cancer Center

Amarillo, Texas, United States

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Houston, Texas, United States

Doctor's Hospital of Laredo

Laredo, Texas, United States

Covenant Medical Center

Lubbock, Texas, United States

Saint Agnes Hospital/Agnesian Cancer Center

Fond du Lac, Wisconsin, United States

ProHealth Waukesha Memorial Hospital

Waukesha, Wisconsin, United States

Cheyenne Regional Medical Center-West

Cheyenne, Wyoming, United States

Clinica del Country

Bogotá, Cundinamarca, Colombia

Instituto de Cancerologia Las Americas

Medellín, Colombia

University of Guadalajara

Guadalajara, Jalisco, Mexico

Salvador Zubiran National Institute of Health Sciences and Nutrition

Mexico City, Tlalpan, Mexico

Monterrey Institute of Technology-TecSalud

Nuevo León, Mexico

Instituto Nacional de Enfermedades Neoplasicas

Lima, Peru

University of Puerto Rico

San Juan, Puerto Rico

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04185935

Related Trials

Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)

NCT076007496 locations

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

NCT0725273938 locations

New Assessment System in Measuring Symptom Distress in Cancer Patients

NCT005052451 location

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

NCT0681864349 locations

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

NCT0763097417 locations